Patent · US Active

Methods for inhibiting conversion of choline to trimethylamine (TMA)

US10751301B2 · kind B2 · utility

0Cited by

3References

4Claims

0Family size

Assignees

The Procter & Gamble Company · US
The Cleveland Clinic Foundation · US

Inventors

Jose Carlos Garcia-Garcia · Cincinnati, US
George Franklin Gerberick · Cincinnati, US
Michael Reilly · Lebanon, US
Stanley L. Hazen · Pepper Pike, US
Xiaodong Gu · Cleveland, US

Key dates

Filing date	Oct 2, 2018
Grant date	Aug 25, 2020
Priority date	—
Expiry date	Oct 2, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.